Evvy
New York-based precision medicine company for women's health focused on the vaginal microbiome, at-home testing and AI-guided care.
- Industry
- women's health, precision medicine, vaginal microbiome
- Location
- New York, NY
- Website
- https://www.evvy.com
- Founded
- 2021
About
Evvy offers an at-home vaginal microbiome test reviewed by clinicians, with personalized treatment plans where relevant. It says it has served more than 100,000 patients and works with about 3,000 practitioners. The company is expanding into fertility research and care models built on its vaginal microbiome dataset.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Series B 2026 | 2026-09-15 | $40M | Catalio Capital Management |
Investors
- Catalio Capital Management lead
- Rethink Impact participant
- Muse Capital participant
- Alumni Ventures participant
- LabCorp Venture Fund participant
- General Catalyst participant
- Left Lane Capital participant
- BBG Ventures participant
Sources
Last verified:
- https://techcrunch.com/2026/09/15/evvy-raises-40m-as-it-seeks-to-further-womens-health-research-with-vaginal-microbiome-data/
Type: reputable publication. Accessed 2026-10-07.
TechCrunch article dated 2026-09-15. Reports the $40 million Series B led by Catalio Capital Management and describes Evvy's at-home vaginal microbiome test and EvvyAI. - https://finance.yahoo.com/healthcare/articles/evvy-raises-40m-series-b-130000745.html
Type: funding announcement. Accessed 2026-10-07.
Business Wire release datelined New York, September 15, 2026, read on Yahoo Finance. Confirms the oversubscribed $40 million Series B led by Catalio and lists new and existing investors.